Daniel H White Net Worth & Insider Trades

Daniel H White - President and CEO, Clearside Biomedical, Inc

As of June 4, 2018

What is Daniel H White's Net Worth?

The current estimated net worth of Clearside Biomedical, Inc's President and CEO, Daniel H White, is estimated to be about $1.1M . Daniel H White owns about 484,523 units of Clearside Biomedical, Inc common stock. In the last year at Clearside Biomedical, Inc, Daniel H White has sold an estimated value of $452.36K worth.

What is Daniel H White's Past Insider Trading?

Daniel H White's largest purchase order was 11,000 units , worth over $99.77K on June 4, 2018. Daniel H White's largest sale order was 16,000 units , worth over $121.08K on September 11, 2017. In total, Daniel H White has made about 7 transactions over a year of their time at Clearside Biomedical, Inc. Daniel H White usually trades in June, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Daniel H White's' Mailing Address?

  • Mailing address is C/o Clearside Biomedical, Inc. 1220 Old Alpharetta Road, Suite 300 Alpharetta GA 30005 GA

Clearside Biomedical, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Lasezkay 2020 $503,313 $286,513 $402,827 $163,577 $14,777 $1,371,007
George Lasezkay 2019 $371,235 $181,772 $299,915 $159,809 $32,461 $1,045,192
Charles A. Deignan 2020 $342,876 $59,250 $152,010 $78,004 $9,450 $641,590
Charles A. Deignan 2019 $332,890 $105,264 $107,753 $106,000 $9,300 $661,207
Thomas Ciulla 2020 $367,375 $59,250 $152,010 $83,578 $9,450 $671,663
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1539029/000119312521135345/d59948ddef14a.htm

What are Clearside Biomedical, Inc's Past Insider Trades?

Clearside Biomedical, Inc's most recent insider trade came on January 20, 2023 by Thomas Ciulla who sold 13,700 units worth $20.14K . In the last 7 years, insiders at Clearside Biomedical, Inc have sold an estimated value of $11.96M and bought an estimated value of $13.85M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Clay Thorp, Director,  Charles Deignan, Chief Financial Officer,  and George Lasezkay, CEO .

Clearside Biomedical, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1